Lüddens H, Seeburg P H, Korpi E R
Laboratory of Molecular Neuroendocrinology, Center for Molecular Biology, Heidelberg, Germany.
Mol Pharmacol. 1994 May;45(5):810-4.
We expressed in cultured cells recombinant gamma-aminobutyric acid type A (GABAA) receptors of the subunit compositions alpha 1 beta j gamma k and alpha 5 beta j gamma k (j = 1, 2, or 3 and k = 2 or 3). A comparison of ligand-binding properties revealed a functional role for individual beta variants, which depended on the alpha subunit in the GABAA receptor. Recombinant alpha 5 beta x gamma 2/3 receptors recognized the cage convulsant t-butylbicyclophosphoro[35S]thionate, as well as the benzodiazepine (BZ) receptor inverse agonist [3H]Ro 15-4513, only with the beta 3 variant. In contrast, the exchange of beta variants in alpha 1 beta x gamma 2 receptors imparted differential modulation of t-butyl-bicyclophosphoro[35S]thionate binding by BZ receptor ligands. The BZ site of gamma 3-containing receptors was partially independent of the accompanying alpha and beta variants. alpha 1/5 beta 3 gamma 3 receptors were zolpidem insensitive but distinguished from alpha 5 beta 3 gamma 2 receptors by high affinity for the partial BZ receptor agonist CI 218,872. The distinct affinities of recombinant receptors for CI 218,872 suggested that the alpha 5 beta 3 gamma 2 receptor is the dominant zolpidem-insensitive GABAA receptor in the brain. Hence, alpha 5 beta 3 gamma 3 recpetors are not a major fraction of the native zolpidem-insensitive receptors, even though their genes are colocalized on mouse chromosome 7 and on human chromosome 15.
我们在培养细胞中表达了亚基组成为α1βjγk和α5βjγk(j = 1、2或3且k = 2或3)的重组γ-氨基丁酸A型(GABAA)受体。配体结合特性的比较揭示了单个β变体的功能作用,这取决于GABAA受体中的α亚基。重组α5βxγ2/3受体仅与β3变体一起才能识别惊厥剂叔丁基双环磷硫代酸酯,以及苯二氮䓬(BZ)受体反向激动剂[3H]Ro 15 - 4513。相比之下,α1βxγ2受体中β变体的交换赋予了BZ受体配体对叔丁基双环磷硫代酸酯结合的差异调节。含γ3受体的BZ位点部分独立于伴随的α和β变体。α1/5β3γ3受体对唑吡坦不敏感,但与α5β3γ2受体的区别在于对部分BZ受体激动剂CI 218,872具有高亲和力。重组受体对CI 218,872的不同亲和力表明α5β3γ2受体是大脑中主要的对唑吡坦不敏感的GABAA受体。因此,α5β3γ3受体不是天然对唑吡坦不敏感受体的主要部分,尽管它们的基因共定位于小鼠7号染色体和人类15号染色体上。